IL296146A - Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities - Google Patents

Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities

Info

Publication number
IL296146A
IL296146A IL296146A IL29614622A IL296146A IL 296146 A IL296146 A IL 296146A IL 296146 A IL296146 A IL 296146A IL 29614622 A IL29614622 A IL 29614622A IL 296146 A IL296146 A IL 296146A
Authority
IL
Israel
Prior art keywords
asc
change
pharmaceutical composition
use according
lsil
Prior art date
Application number
IL296146A
Other languages
English (en)
Hebrew (he)
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of IL296146A publication Critical patent/IL296146A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL296146A 2020-03-03 2021-03-03 Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities IL296146A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
PCT/EP2021/055230 WO2021175877A1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (1)

Publication Number Publication Date
IL296146A true IL296146A (en) 2022-11-01

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
IL296146A IL296146A (en) 2020-03-03 2021-03-03 Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities

Country Status (23)

Country Link
US (1) US20230092142A1 (cg-RX-API-DMAC7.html)
EP (2) EP3875083A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840859B2 (cg-RX-API-DMAC7.html)
CN (1) CN115279358A (cg-RX-API-DMAC7.html)
AR (1) AR122387A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021231205B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022017436A2 (cg-RX-API-DMAC7.html)
CL (1) CL2022002363A1 (cg-RX-API-DMAC7.html)
CY (1) CY1126764T1 (cg-RX-API-DMAC7.html)
ES (1) ES2976058T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240374T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066384T2 (cg-RX-API-DMAC7.html)
IL (1) IL296146A (cg-RX-API-DMAC7.html)
MA (1) MA58262B1 (cg-RX-API-DMAC7.html)
MD (1) MD4084788T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022010838A (cg-RX-API-DMAC7.html)
PL (1) PL4084788T3 (cg-RX-API-DMAC7.html)
RS (1) RS65349B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400126T1 (cg-RX-API-DMAC7.html)
TW (1) TW202146004A (cg-RX-API-DMAC7.html)
UA (1) UA130108C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021175877A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202208848B (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Also Published As

Publication number Publication date
US20230092142A1 (en) 2023-03-23
EP3875083A1 (en) 2021-09-08
RS65349B1 (sr) 2024-04-30
CL2022002363A1 (es) 2023-03-31
JP7840859B2 (ja) 2026-04-06
ES2976058T3 (es) 2024-07-22
EP4084788A1 (en) 2022-11-09
WO2021175877A1 (en) 2021-09-10
CY1126764T1 (el) 2026-02-25
ZA202208848B (en) 2024-09-25
AU2021231205A1 (en) 2022-09-01
CN115279358A (zh) 2022-11-01
BR112022017436A2 (pt) 2022-10-18
EP4084788B1 (en) 2024-02-14
TW202146004A (zh) 2021-12-16
CA3167015A1 (en) 2021-09-10
AU2021231205B2 (en) 2026-02-26
MD4084788T2 (ro) 2024-06-30
MA58262B1 (fr) 2024-03-29
PL4084788T3 (pl) 2024-06-03
UA130108C2 (uk) 2025-11-12
JP2023516153A (ja) 2023-04-18
AR122387A1 (es) 2022-09-07
HUE066384T2 (hu) 2024-07-28
SMT202400126T1 (it) 2024-05-14
EP4084788C0 (en) 2024-02-14
MX2022010838A (es) 2022-09-27
HRP20240374T1 (hr) 2024-06-07

Similar Documents

Publication Publication Date Title
US11213544B2 (en) Application of alginic acid sulfate in preparation of drugs and health care products for preventing and treating diseases caused by human papilloma viruses
CN102670588B (zh) 鞣花酸用于制备抗病毒药物的应用
CN101181636B (zh) 一种防治人乳头瘤病毒感染的复方疫苗组合物、复方疫苗阴道喷雾剂及其用途
JP2021525266A5 (cg-RX-API-DMAC7.html)
CN107582563B (zh) 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂
JP2021536454A5 (cg-RX-API-DMAC7.html)
IL296146A (en) Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities
CN103599093B (zh) 一种抗hpv药物制剂及用途
EP3843715B1 (en) Therapy of high-risk human papillomavirus infections
CN113304251A (zh) 一种组合物在抗人乳头瘤病毒中的应用
CN114053475A (zh) 一种抗hpv医用妇科敷料
JP2023516153A5 (cg-RX-API-DMAC7.html)
CN114053392A (zh) 新型化合物在制备预防和/或治疗hpv感染的药物中的应用
CN115154482B (zh) 硫化铁纳米酶抗人乳头瘤病毒的用途
CA3167015C (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN103800684A (zh) 一种中西药同步外用治疗宫颈人乳头病毒(hpv)、上皮内瘤变(cin)及宫颈糜烂的根治术
Arab A Gynecological Oncovirus: HPV and Cervical Cancer
CN117224539A (zh) 苯并咪唑类化合物在制备预防或治疗hpv感染的药物中的应用
HK40045218A (en) Therapy of high-risk human papillomavirus infections
HK40045218B (en) Therapy of high-risk human papillomavirus infections
EA048333B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
HK40074763A (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK40074763B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN115581760A (zh) 一种用于hpv病毒防治的凝胶及其制备方法